Skip to main content
Caplight Logo









Praeventix

Praeventix

Private
Exton, PennsylvaniaHealthcare & Life Scienceshttps://praeventix.com/

Last Round

Series A

Feb 13, 2026

Total Funding Raised

$7.2M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Praeventix is a biotechnology company that develops novel serotonergic therapeutics and signal transduction-modulating agents for the treatment of inflammatory, dermatologic, and neurodegenerative diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticaldrug discovery5-HT7 receptor antagonistchronic pruritustopical therapeuticsneuromodulatorysmall moleculepreclinical developmentbiotech startupsmall business innovation researchSBIRitch treatmentinflammatory diseasedrug pipelinebiotech R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Praeventix Comparables

Compare Praeventix with similar companies based on industry and business-model similarity.

Praeventix comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Incyte Corporation
71%
Evommune
64%
Galderma
60%

Praeventix Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AFeb 13, 2026
SeedNov 8, 2022

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 13, 2026

    Completed a Series A funding round.

Praeventix Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Praeventix Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Praeventix's valuation, stock price, and market status.

Firmographic Details

HeadquartersExton, Pennsylvania
Year Founded2015
Last FundingFeb 13, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?